|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Procurement revenue | |||||
| Contract and grant revenue | |||||
| Licensing revenue | |||||
| Royalty revenue | |||||
| Total revenues | |||||
| Cost of goods sold | |||||
| Gross Profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Acquired in-process research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Interest income and other, net | |||||
| Gain on sale of business, net | |||||
| (Loss) income before income taxes | |||||
| Income tax expense | |||||
| Net (loss) income | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain (loss) on debt investments, net | |||||
| Comprehensive (loss) income | |||||
| Per share information: | |||||
| Net (loss) income, basic (in dollars per share) | |||||
| Net (loss) income, diluted (in dollars per share) | |||||
| Weighted-average shares outstanding, basic (in shares) | |||||
| Weighted-average shares outstanding, diluted (in shares) | |||||
Loading...